Navigation Links
Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop

.

Clonal Analysis of Samples from Virologic Responders Receiving Racivir in Study 201

De La Rosa A, Lloyd R, Otto MJ

Study Conclusion: Racivir effectively reduced viral loads by a mean of 0.7 log10 (80% reduction) in responders harboring the M184V mutation and fewer than 3 TAMs at day 28. Clonal genotypic analysis of virus from responders indicated that the M184V mutation was found on all clones in addition to multidrug resistance-associated mutations observed with first line therapy failure.

About Clevudine

Clevudine is an oral, once-daily pyrimidine nucleoside analog that is in development for the treatment of HBV. Clevudine is approved for HBV in Korea, and it is marketed by Bukwang Pharmaceuticals under the brand name Levovir. In addition to its on-treatment efficacy, Clevudine has demonstrated sustained virologic response (SVR) for HBV, or undetectable virus 24 weeks after stopping therapy. We plan to initiate two Phase 3 clinical trials of Clevudine for registration in the United States, Europe and South America in the third calendar quarter of 2007.

About Racivir

Racivir is an oral, once-daily cytidine nucleoside analog that is in development as an HIV therapy for use in combination with other approved HIV drugs. We have completed a Phase 2 clinical trial, Study 201, to assess the safety, tolerability and antiviral effect of a 600 mg dose of Racivir head-to- head against lamivudine in HIV-infected, treatment-experienced patients with the M184V mutation who have been on lamivudine therapy. Racivir demonstrated antiviral activity in patients harboring HIV with the M184V mutation and less than three thymidine analog mutations. These patients have genotypes consistent with first-line HIV therapy failure and may be candidates for second-line treatment regimens that contain Racivir. Future studies will be designed to explore this potential use of Racivir in a combination therapy for second-line therapy for HIV.

<
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Pharmasset Announces Clevudine and Hepatitis C Presentations at EASL
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
(Date:5/27/2015)...  Nurtur Health, Inc. (Nurtur), a wholly owned subsidiary ... honored by Dorland Health,s Case in Point ... to Peach State Health Plan,s teenage members with asthma. ... Platinum Awards recognize population health management programs that successfully ... and settings in the continuum of care coordination. Nurtur ...
(Date:5/27/2015)... May 27, 2015   AMC Health , a ... that it has successfully undergone a third-party review of ... 21 CFR 820 and 21 CFR 11 for its ... the first of its kind for clinical trials. ... of quality assurance/regulatory compliance and business operations in the ...
(Date:5/27/2015)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) and ... Roche Group, announced today a global agreement to collaborate ... commercialize, a companion diagnostic assay for use with Halozyme,s ... assay will be used to identify high levels of ... natural sugars distributed throughout human tissue – that can ...
Breaking Medicine Technology:Nurtur's Asthma Management Program Wins Award from Dorland Health 2AMC Health Quality Management System for Telehealth in Clinical Trials Use Compliant with 21 CFR 820 and 21 CFR 11 Requirements 2Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 2Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 4Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 5
(Date:5/27/2015)... Tx (PRWEB) May 27, 2015 ... germline pharmacogenomic and somatic genomic analysis in personalized cancer ... published by the American Society of Clinical Oncology (ASCO) ... June 2 in Chicago. , The molecular and clinical ... Cancer Genome Atlas (TCGA) database. The study reports improved ...
(Date:5/27/2015)... Ohio (PRWEB) May 27, 2015 Cincinnati Veterans ... & Research for Veterans (CERV) Foundation is proud to host ... fair for women Veterans June 11 at the Freedom Center ... Karin Johnson will be the emcee. , This event ... devotion to the nation. The banquet is free to ...
(Date:5/27/2015)... IL (PRWEB) May 27, 2015 ... of its SonarMD Platform, a first-of-its kind, ... and managing patients with chronic gastrointestinal disease. ... MD, MBA, the application allows physicians to ... through the ongoing use of electronic health ...
(Date:5/27/2015)... May 27, 2015 With a prevalently ... poll conducted during the "ACA - Controlling the Chaos" ... 75% are currently in the process of researching ... were confidently prepared for the reporting mandates. , According ... the webinar, those who are currently vetting ACA reporting ...
(Date:5/27/2015)... 2015 A television program using health ... and Roswell Park Cancer Institute winning a ... story, Cancer Can’t Win , highlights the amazing ... Institute. The production team followed five people who were ... they received treatment from doctors and medical experts at ...
Breaking Medicine News(10 mins):Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3
... Jewish Health has received a grant for $950,308 from ... San Luis Valley with educational materials for patients and ... the most common chronic illness in children and adults, ... The San Luis Valley has one of the highest ...
... his State of the State announcement of a tenfold ... Kasich joined medical researchers from across the state on ... the faster network speeds will help enhance innovation. ... Medical Center, Case Western Reserve University School of Medicine, ...
... Mann HealthDay Reporter , MONDAY, Feb. 27 (HealthDay ... much needed rest at night, but using them routinely might ... develop certain types of cancer, research suggests. A new ... times more likely to die than people who don,t take ...
... is studying the differences between the social impairments found ... for people with both disorders. Autism spectrum disorder ... but they share similarities in social dysfunction. For many ... young people with ASD were thought to have a ...
... heart disease may not be able to compensate for their ... to Penn State researchers, making snow shoveling and other activities ... why cold air is such a trigger for coronary events," ... of the Heart and Vascular Institute, Penn State College of ...
... EAST LANSING, Mich. Often faced with overwhelming anxiety, patients ... and new research recommends nurses play a key role in ... patients. A diagnosis of lung cancer the leading ... with it high levels of stress and raises existential issues ...
Cached Medicine News:Health News:National Jewish Health receives grant to improve care of asthma patients in the San Luis Valley 2Health News:National Jewish Health receives grant to improve care of asthma patients in the San Luis Valley 3Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 2Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 3Health News:Sleeping Pills Linked to Raised Risk of Death, Cancer: Study 2Health News:Sleeping Pills Linked to Raised Risk of Death, Cancer: Study 3Health News:Study compares traits of autism, schizophrenia 2Health News:Cold air chills heart's oxygen supply 2Health News:Nurses key in helping new cancer patients overcome fears 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: